Ahrens Investment Partners LLC Abb Vie Inc. Transaction History

Ahrens Investment Partners LLC

$200 Million
Q1 2023

A detailed history of Ahrens Investment Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 13,675 shares of ABBV stock, worth $2.32 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares

13,675

Previous 14,930 8.41%

Holding current value

$2.32 Million

Previous $2.41 Million 9.73%

% of portfolio

1.09%

Previous 1.1%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $181,485 - $209,007	-1,255 Reduced 8.41%	13,675 $2.18 Million
Q4 2022 Feb 08, 2023	SELL	$138.31 - $165.87 $127,660 - $153,098	-923 Reduced 5.82%	14,930 $2.41 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $187,491 - $215,040	-1,397 Reduced 8.1%	15,853 $2.13 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $779,204 - $990,623	-5,662 Reduced 24.71%	17,250 $2.64 Million
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $1.76 Million - $2.18 Million	13,323 Added 138.94%	22,912 $3.71 Million
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $75,738 - $95,830	705 Added 7.94%	9,589 $1.3 Million
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $3,830 - $4,348	-36 Reduced 0.4%	8,884 $958,000
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $10,521 - $11,721	100 Added 1.13%	8,920 $1.01 Million
Q1 2021 May 05, 2021	SELL	$102.3 - $112.62 $202,042 - $222,424	-1,975 Reduced 18.3%	8,820 $955,000
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $122,022 - $164,743	1,516 Added 16.34%	10,795 $1.16 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $509,961 - $598,526	-5,936 Reduced 39.01%	9,279 $813,000
Q2 2020 Jul 15, 2020	BUY	$73.37 - $98.18 $874,643 - $1.17 Million	11,921 Added 361.9%	15,215 $1.49 Million
Q1 2020 Apr 24, 2020	SELL	$64.5 - $97.79 $32,250 - $48,895	-500 Reduced 13.18%	3,294 $251,000
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $273,661 - $342,408	3,794 New	3,794 $335,000
Q1 2019 May 02, 2019	SELL	$77.14 - $90.79 $269,835 - $317,583	-3,498 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $272,319 - $335,842	3,498 New	3,498 $322,000
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $199,580 - $236,149	-2,223 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$92.01 - $123.21 $46,649 - $62,467	-507 Reduced 18.57%	2,223 $210,000
Q4 2017 Feb 08, 2018	SELL	$89.56 - $98.21 $11,195 - $12,276	-125 Reduced 4.38%	2,730 $264,000
Q3 2017 Oct 19, 2017	SELL	$69.85 - $89.22 $24,587 - $31,405	-352 Reduced 10.98%	2,855 $254,000
Q2 2017 Aug 14, 2017	BUY	N/A	14 Added 0.44%	3,207 $219,000
Q1 2017 Aug 22, 2017	BUY	N/A	3,193	3,193 $208,000

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ahrens Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ahrens Investment Partners LLC with notifications on news.

Account

Ahrens Investment Partners LLC Abb Vie Inc. Transaction History